DIGESTAID

DigestAID develops artificial intelligence solutions designed to support clinical decision-making in digestive healthcare, gynecology, and pulmonology. Based in Porto, Portugal, the company combines medical and engineering expertise to create deep-learning technologies in partnership with care institutions and clinical experts. Its tools are intended to help clinicians identify findings in endoscopy and other medical video, supporting more informed review and diagnosis.

DigestAID’s technologies address several areas, including capsule endoscopy, capsule colonoscopy, device-assisted enteroscopy, and respiratory and gynecological applications. Examples include distinguishing normal small-bowel mucosa from lesions, detecting ulcers and erosions relevant to inflammatory bowel disease assessment, identifying colon polyps and precursor lesions, and detecting gastrointestinal lesions across the digestive tract. The company presents its AI as support for clinicians, rather than a replacement for clinical judgment.

DigestAID reports partnerships with clinicians and institutions in more than 30 countries and highlights its research, patents, publications, and awards. Regulatory status varies by product and market, so certification details are provided on individual product pages. The company shares updates through its website and LinkedIn.